KLK3 and benign prostatic hyperplasia: In contrast, studies of free isoforms including BPH-specific PSA (BPSA) and pro-PSA (an inactive PSA precursor) have shown increased detection of clinically relevant cancers in patients with 2–10 ng/ml PSA and improved ability to differentiate from BPH (14).